封面
市場調查報告書
商品編碼
2039022

伴侶動物用藥品市場:依產品類型、通路和地區分類

Companion Animal Drugs Market, By Product Type, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年,伴侶動物用藥品市場規模估計為288億美元,預計2033年將達到449億美元。預計2026年至2033年,該市場將以6.8%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 288億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.80% 2033年市場規模預測: 449億美元

伴侶動物包括狗、貓、魚、鳥、馬、兔子、倉鼠、天竺鼠和雪貂。伴侶動物用於陪伴、娛樂、心理支持、外向表達以及人類需要與其他動物物種共用的所有其他功能。預計在預測期內,伴侶動物飼養量的增加將推動全球伴侶動物用藥品市場的成長。此外,不斷上漲的動物醫療保健成本以及沙門氏菌感染疾病的高發生率預計也將推動預測期內的市場成長。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究基於以下參數分析了全球伴侶動物用藥品市場的主要參與者:公司概況、財務績效、產品系列、市場地位、分銷策略、關鍵發展、策略和未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 《全球伴侶動物用藥品市場》報告的目標受群眾外包括該行業的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球伴侶動物用藥品市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 產品核准
  • 合作關係、併購
  • 監理情勢
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 強大的管道分析

第4章 全球伴侶動物用藥品市場:依產品類型分類,2026-2033年

  • 抗生素
  • 抗發炎藥
  • 驅蟲
  • 體外寄生蟲控制藥物
  • 體內寄生蟲控制藥物
  • 預防犬心絲蟲的藥物
  • 行為管理產品
  • 營養補充品
  • 保養品
  • 疫苗

第5章 全球伴侶動物用藥品市場:依通路分類,2026-2033年

  • 動物醫院
  • 動物醫院
  • 藥局和藥局

第6章 全球伴侶動物用藥品市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • Zoetis Inc.
    • Merck &Co., Inc.
    • Bayer AG
    • Eli Lily &Co.
    • Sanofi(Merial)
    • Ceva Sante Animal
    • Virbac Animal Health
    • Boehringer Ingelheim GmbH

第8章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI1203

Companion Animal Drugs Market is estimated to be valued at USD 28.8 Bn in 2026 and is expected to reach USD 44.9 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 28.8 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.80% 2033 Value Projection: USD 44.9 Bn

Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. Furthermore, high prevalence of salmonella infection, along with increasing animal healthcare expenditure is also anticipated to assist the market growth during the forecast period.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Companion Animal Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Sante Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Companion Animal Drugs market

Market Segmentation

  • By Product Type
    • Antibiotics
    • Anti-inflammatory
    • Parasiticides
    • Ecto-Parasiticides
    • Endo-Parasiticides
    • Heart worm Products
    • Behavioral Products
    • Nutritional Products
    • Skin care Products
    • Vaccines
  • By Distribution Channel
    • Veterinary Hospitals
    • Veterinary Clinics
    • Pharmacies and Drug Stores
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Bayer AG
    • Eli Lily & Co.
    • Sanofi (Merial)
    • Ceva Sante Animal
    • Virbac Animal Health
    • Boehringer Ingelheim GmbH

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Companion Animal Drugs Market, By Product Type, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026- 2033
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Anti-inflammatory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Ecto-Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Endo-Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Heart worm Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Behavioral Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Nutritional Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Skin care Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Global Companion Animal Drugs Market, By Distribution Channel, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Pharmacies and Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Global Companion Animal Drugs Market, By Region, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Zoetis Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Eli Lily & Co.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sanofi (Merial)
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Ceva Sante Animal
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Virbac Animal Health
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us